Results 121 to 130 of about 51,793 (265)
Objective Cerebral ischemic stroke causes neuronal oxygen/energy deprivation, disrupting mitochondrial function including reduced membrane potential and bioenergetics, exacerbating neuronal injury. Mitochondrial defects are, therefore, a central neuropathological node and potential therapeutic target.
Ning Bian +9 more
wiley +1 more source
Abstract Blockage of blood flow in arteries or veins by blood clots can lead to serious medical conditions. Mechanical thrombectomy (MT), minimally invasive endovascular procedures that utilize aspiration, stent retriever, or cutting mechanisms for clot removal have emerged as an effective treatment modality for ischemic stroke, myocardial ...
Ruike Renee Zhao +7 more
openaire +2 more sources
Prevalence and Risk Factors for Cerebral Microbleeds in Chinese Patients With Acute Ischemic Stroke
Approximately half of the patients with AIS exhibited CMBs, particularly those classified under LAA and SVD subtypes. Hypertension and severe WMH were independently associated with CMB presence. Distinct clinical profiles were observed based on CMB burden and location.
Ruiming Zhu +5 more
wiley +1 more source
Tenecteplase for Thrombectomy Thrombolysis [PDF]
Robert M Starke +3 more
openaire +2 more sources
OBJECTIVES Embolic Stroke of Undetermined Source (ESUS) is a distinct stroke entity that disproportionately affects young adults. We sought to describe characteristics, workup and outcomes of young adult ESUS patients who underwent thrombectomy, and ...
Meseguer, Elena +9 more
core +1 more source
Catheter for percutaneous thrombectomy: first clinical experience
The authors evaluated a double-lumen thrombectomy catheter that functions by way of the Venturi effect in seven consecutive patients with thrombus in the superficial femoral artery.
Reekers, J. A. +2 more
core +1 more source
Graphical representation of the comparative efficacy and safety of intravenous tirofiban for acute ischemic stroke in randomized controlled trials. ABSTRACT Background: Tirofiban is a GP IIb/IIIa inhibitor, an anti‐platelet drug that is used in ischemic stroke or acute coronary syndromes.
Dorothy Lim Bullecer +12 more
wiley +1 more source
Objective To investigate the association between early spontaneous blood pressure (BP) reductions after thrombectomy, without pharmacological intervention, and clinical outcomes in patients with acute anterior circulation large vessel occlusion (LVO ...
Jianwen Bu, Guosen Bu, Yang Zhang
doaj +1 more source

